{"database": "openregs", "table": "documents", "rows": [["FDA-1976-N-0520-0012", "FDA", "FDA-1976-N-0520", "Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing", "Notice", "Notice of Opportunity of Hearing", "2003-04-16T04:00:00Z", 2003, 4, null, null, "2020-02-20T15:27:16Z", "03-9065", 0, 0, "090000648053be8e"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1976-N-0520-0012"], "units": {}, "query_ms": 2.6384289376437664, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}